| Year |
Citation |
Score |
| 2024 |
Bigdeli TB, Barr PB, Rajeevan N, Graham DP, Li Y, Meyers JL, Gorman BR, Peterson RE, Sayward F, Radhakrishnan K, Natarajan S, Nielsen DA, Wilkinson AV, Malhotra AK, Zhao H, ... ... Kosten TR, et al. Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Molecular Psychiatry. PMID 38491344 DOI: 10.1038/s41380-024-02472-1 |
0.495 |
|
| 2023 |
Barr PB, Bigdeli TB, Meyers JL, Peterson RE, Sanchez-Roige S, Mallard TT, Dick DM, Harden KP, Wilkinson A, Graham DP, Nielsen DA, Swann AC, Lipsky RK, Kosten TR, Aslan M, et al. Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort. Jama Psychiatry. PMID 37938835 DOI: 10.1001/jamapsychiatry.2023.4141 |
0.468 |
|
| 2023 |
Aloi MS, Poblete GF, Oldham J, Patriquin MA, Nielsen DA, Kosten TR, Salas R. miR-124-3p target genes identify globus pallidus role in suicide ideation recovery in borderline personality disorder. Npj Mental Health Research. 2: 8. PMID 37712050 DOI: 10.1038/s44184-023-00027-w |
0.445 |
|
| 2023 |
Barr PB, Bigdeli TB, Meyers JL, Peterson RE, Sanchez-Roige S, Mallard TT, Dick DM, Harden KP, Wilkinson A, Graham DP, Nielsen DA, Swann A, Lipsky RK, Kosten T, Aslan M, et al. Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort. Medrxiv : the Preprint Server For Health Sciences. PMID 37034805 DOI: 10.1101/2023.03.22.23286865 |
0.485 |
|
| 2023 |
Bigdeli TB, Barr PB, Rajeevan N, Graham DP, Li Y, Meyers JL, Gorman BR, Peterson RE, Sayward F, Radhakrishnan K, Natarajan S, Nielsen DA, Wilkinson AV, Malhotra AK, Zhao H, ... ... Kosten TR, et al. Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Medrxiv : the Preprint Server For Health Sciences. PMID 36945597 DOI: 10.1101/2023.03.06.23286866 |
0.471 |
|
| 2022 |
Kosten TR, Domingo CB, Haile CN, Nielsen DA. A Clinical Trial of Entolimod a TLR-5 Adjuvant for Vaccines Using Diphtheria or Tetanus as Carrier Proteins. Vaccines. 10. PMID 36298456 DOI: 10.3390/vaccines10101592 |
0.467 |
|
| 2022 |
Poblete G, Nguyen T, Gosnell S, Sofela O, Patriquin M, Mathew SJ, Swann A, Nielsen DA, Kosten TR, Salas R. A Novel Approach to Link Genetics and Human MRI Identifies AKAP7-Dependent Subicular/Prefrontal Functional Connectivity as Altered in Suicidality. Chronic Stress (Thousand Oaks, Calif.). 6: 24705470221083700. PMID 35340866 DOI: 10.1177/24705470221083700 |
0.45 |
|
| 2022 |
Nielsen DA, Walker R, Graham DP, Nielsen EM, Hamon SC, Hillhouse M, Shmueli-Blumberg D, Lawson WB, Shores-Wilson K, Settles-Reaves BD, Rotrosen J, Trivedi MH, Saxon AJ, Ling W, Kosten TR. Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene. European Journal of Clinical Pharmacology. PMID 35218405 DOI: 10.1007/s00228-022-03302-5 |
0.596 |
|
| 2021 |
Thomas PS, Nielsen EM, Spellicy CJ, Harding MJ, Ye A, Patriquin M, Hamon SC, Kosten TR, Nielsen DA. The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. Psychiatric Genetics. 31: 88-94. PMID 33953123 DOI: 10.1097/YPG.0000000000000279 |
0.588 |
|
| 2020 |
Kosten T, Aharonovich E, Nangia N, Zavod A, Akerman SC, Lopez-Bresnahan M, Sullivan MA. Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial. Addictive Behaviors. 111: 106538. PMID 32777606 DOI: 10.1016/J.Addbeh.2020.106538 |
0.304 |
|
| 2020 |
Sun Y, Li Y, Bao Y, Meng S, Sun Y, Schumann G, Kosten T, Strang J, Lu L, Shi J. Brief Report: Increased Addictive Internet and Substance Use Behavior During the COVID-19 Pandemic in China. The American Journal On Addictions. PMID 32500608 DOI: 10.1111/Ajad.13066 |
0.327 |
|
| 2020 |
Oh H, Lee J, Gosnell SN, Patriquin M, Kosten T, Salas R. Orbitofrontal, dorsal striatum, and habenula functional connectivity in psychiatric patients with substance use problems. Addictive Behaviors. 108: 106457. PMID 32371303 DOI: 10.1016/J.Addbeh.2020.106457 |
0.313 |
|
| 2020 |
Sun Y, Bao Y, Kosten T, Strang J, Shi J, Lu L. Editorial: Challenges to Opioid Use Disorders During COVID-19. The American Journal On Addictions. PMID 32281130 DOI: 10.1111/Ajad.13031 |
0.302 |
|
| 2020 |
Poblete GF, Gosnell SN, Meyer M, Fang M, Nguyen T, Patriquin MA, Nielsen D, Kosten T, Salas R. Process Genes List: An Approach to Link Genetics and Human Brain Imaging. Journal of Neuroscience Methods. 108695. PMID 32201351 DOI: 10.1016/J.Jneumeth.2020.108695 |
0.494 |
|
| 2020 |
Xu A, Kosten TR. Current status of immunotherapies for addiction. Annals of the New York Academy of Sciences. PMID 32147860 DOI: 10.1111/Nyas.14329 |
0.35 |
|
| 2020 |
Mathai DS, Meyer MJ, Storch EA, Kosten TR. The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Journal of Affective Disorders. 264: 123-129. PMID 32056741 DOI: 10.1016/J.Jad.2019.12.023 |
0.301 |
|
| 2020 |
Shorter DI, Zhang X, Domingo CB, Nielsen EM, Kosten TR, Nielsen DA. Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an genetic variant. The American Journal of Drug and Alcohol Abuse. 1-10. PMID 31914324 DOI: 10.1080/00952990.2019.1674864 |
0.644 |
|
| 2020 |
Salas R, Poblete G, Nguyen T, Patriquin M, Nielsen D, Kosten T. A Novel Strategy to Identify Genetic/Brain Imaging Interactions Suggests Habenular Connectivity is Associated With Suicidality Biological Psychiatry. 87: S35. DOI: 10.1016/J.Biopsych.2020.02.111 |
0.498 |
|
| 2019 |
Holst M, Mathai DS, Patel MM, Rodgman C, Keller J, Hussain MZ, De La Garza R, Kosten TR, Verrico CD. Use of Guanfacine for Cannabis use Disorder and Related Symptomology. The American Journal On Addictions. PMID 31483544 DOI: 10.1111/Ajad.12959 |
0.315 |
|
| 2019 |
Patel B, Kosten TR. Keeping up with clinical advances: opioid use disorder-Addendum. Cns Spectrums. 24: 83. PMID 31482775 DOI: 10.1017/S1092852919001421 |
0.305 |
|
| 2019 |
Hermes G, Hyman SM, Fogelman N, Kosten TR, Sinha R. Lofexidine in Combination with Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A pilot Randomized, Double-Blind, Placebo-Controlled Study. The American Journal On Addictions. PMID 31448846 DOI: 10.1111/Ajad.12942 |
0.335 |
|
| 2019 |
Patel B, Kosten TR. Keeping Up with Clinical Advances: Opioid Use Disorder. Cns Spectrums. 1-7. PMID 31290386 DOI: 10.1017/S109285291900110X |
0.349 |
|
| 2019 |
Kampangkaew JP, Spellicy CJ, Nielsen EM, Harding MJ, Ye A, Hamon SC, Kosten TR, Nielsen DA. Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. The American Journal On Addictions. PMID 31087723 DOI: 10.1111/Ajad.12891 |
0.617 |
|
| 2019 |
Deng H, Desai PV, Mohite S, Okusaga OO, Zhang XY, Nielsen DA, Kosten TR. Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users. Journal of Studies On Alcohol and Drugs. 80: 230-235. PMID 31014468 DOI: 10.15288/Jsad.2019.80.230 |
0.519 |
|
| 2019 |
Yang F, Kosten TR. Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists. Psychopharmacology. PMID 30726515 DOI: 10.1007/S00213-019-5176-9 |
0.383 |
|
| 2019 |
Kosten TR, Baxter LE. Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment. The American Journal On Addictions. PMID 30701615 DOI: 10.1111/Ajad.12862 |
0.316 |
|
| 2019 |
Lake EP, Mitchell BG, Shorter DI, Kosten T, Domingo CB, Walder AM. Buprenorphine for the treatment of posttraumatic stress disorder. The American Journal On Addictions. PMID 30664299 DOI: 10.1111/Ajad.12860 |
0.313 |
|
| 2018 |
Patel MM, Nielsen DA, Kosten TR, De La Garza R, Newton TF, Verrico CD. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. The American Journal On Addictions. PMID 30126012 DOI: 10.1111/Ajad.12788 |
0.632 |
|
| 2018 |
Deng H, Verrico CD, Kosten TR, Nielsen DA. Psychosis and synthetic cannabinoids. Psychiatry Research. 268: 400-412. PMID 30125871 DOI: 10.1016/J.Psychres.2018.08.012 |
0.544 |
|
| 2018 |
Kosten TR, Graham DP, Nielsen DA. Opioid Use Disorder After Self-medicating Pain From Traumatic Brain Injury. Jama Psychiatry. PMID 29710138 DOI: 10.1001/Jamapsychiatry.2018.0098 |
0.528 |
|
| 2018 |
Kosten TR, Graham DP, Nielsen DA. Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury. Jama Psychiatry. PMID 29710079 DOI: 10.1001/Jamapsychiatry.2018.0101 |
0.547 |
|
| 2018 |
Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. Drug and Alcohol Dependence. 187: 171-178. PMID 29674251 DOI: 10.1016/J.Drugalcdep.2018.02.023 |
0.311 |
|
| 2018 |
Bisaga A, Mannelli P, Sullivan MA, Vosburg SK, Compton P, Woody GE, Kosten TR. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies. The American Journal On Addictions. 27: 177-187. PMID 29596725 DOI: 10.1111/Ajad.12711 |
0.329 |
|
| 2018 |
Zhang X, Nielsen DA, Domingo CB, Shorter DI, Nielsen EM, Kosten TR. Pharmacogenetics of Dopamine β-Hydroxylase in cocaine dependence therapy with doxazosin. Addiction Biology. PMID 29498170 DOI: 10.1111/Adb.12611 |
0.637 |
|
| 2017 |
Bashiri M, Mancino MJ, Stanick VA, Thostenson J, Kosten TR, Oliveto AH. Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials. The American Journal On Addictions. PMID 29115703 DOI: 10.1111/Ajad.12635 |
0.41 |
|
| 2017 |
Ma L, Steinberg JL, Cunningham KA, Bjork JM, Lane SD, Schmitz JM, Burroughs T, Narayana PA, Kosten TR, Bechara A, Moeller FG. Altered anterior cingulate cortex to hippocampus effective connectivity in response to drug cues in men with cocaine use disorder. Psychiatry Research. PMID 29108734 DOI: 10.1016/J.Pscychresns.2017.10.012 |
0.397 |
|
| 2017 |
Heekin RD, Shorter D, Kosten TR. Current status and future prospects for the development of substance abuse vaccines. Expert Review of Vaccines. 16: 1067-1077. PMID 28918668 DOI: 10.1080/14760584.2017.1378577 |
0.363 |
|
| 2017 |
Curtis K, Viswanath H, Velasquez KM, Molfese DL, Harding MJ, Aramayo E, Baldwin PR, Ambrosi E, Madan A, Patriquin M, Frueh BC, Fowler JC, Kosten TR, Nielsen DA, Salas R. Increased habenular connectivity in opioid users is associated with an α5 subunit nicotinic receptor genetic variant. The American Journal On Addictions. PMID 28857330 DOI: 10.1111/Ajad.12607 |
0.557 |
|
| 2017 |
Nielsen DA, Shorter D, Domingo C, Harding M, Nielsen EM, Kosten T. Adrenoceptor variants moderate treatment response of doxazosin for cocaine use disorder Drug and Alcohol Dependence. 171: e152. DOI: 10.1016/J.Drugalcdep.2016.08.420 |
0.637 |
|
| 2017 |
Moeller FG, Ma L, Steinberg J, Bjork J, Lane SD, Narayana P, Kosten T, Bechara A, Schmitz J, Price AE, Cunningham KA. Effective connectivity of attentional bias in cocaine dependence Drug and Alcohol Dependence. 171: e147. DOI: 10.1016/J.Drugalcdep.2016.08.405 |
0.415 |
|
| 2017 |
Blokhina E, Krupitsky E, Kibitov A, Verbitskaya E, Kosten T, Nielsen DA, Zvartau E. The role of genetic polymorphisms on patient response to opioid use disorder therapy with naltrexone and guanfacine Drug and Alcohol Dependence. 171: e21. DOI: 10.1016/J.Drugalcdep.2016.08.072 |
0.555 |
|
| 2016 |
Ayanga D, Shorter D, Kosten TR. Update on Pharmacotherapy for Treatment of Opioid Use Disorder. Expert Opinion On Pharmacotherapy. PMID 27734745 DOI: 10.1080/14656566.2016.1244529 |
0.332 |
|
| 2016 |
Sharp C, Fowler JC, Salas R, Nielsen D, Allen J, Oldham J, Kosten T, Mathew S, Madan A, Frueh BC, Fonagy P. Operationalizing NIMH Research Domain Criteria (RDoC) in naturalistic clinical settings. Bulletin of the Menninger Clinic. 80: 187-212. PMID 27583809 DOI: 10.1521/Bumc.2016.80.3.187 |
0.522 |
|
| 2016 |
Shorter D, Nielsen DA, Hamon SC, Nielsen EM, Kosten TR, Newton TF, De La Garza R. The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenetics and Genomics. PMID 27379509 DOI: 10.1097/Fpc.0000000000000234 |
0.64 |
|
| 2016 |
Kosten TR. An Opioid for Depression? The American Journal of Psychiatry. 173: 446-7. PMID 27133402 DOI: 10.1176/Appi.Ajp.2016.16010078 |
0.352 |
|
| 2016 |
Li X, Shorter D, Kosten TR. Buprenorphine Prescribing: To Expand or Not to Expand. Journal of Psychiatric Practice. 22: 183-192. PMID 27123798 DOI: 10.1097/Pra.0000000000000154 |
0.332 |
|
| 2015 |
Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Research. 230: 44-9. PMID 26239766 DOI: 10.1016/J.Psychres.2015.07.073 |
0.465 |
|
| 2015 |
Ma L, Steinberg JL, Cunningham KA, Lane SD, Bjork JM, Neelakantan H, Price AE, Narayana PA, Kosten TR, Bechara A, Moeller FG. Inhibitory behavioral control: A stochastic dynamic causal modeling study comparing cocaine dependent subjects and controls. Neuroimage. Clinical. 7: 837-47. PMID 26082893 DOI: 10.1016/J.Nicl.2015.03.015 |
0.335 |
|
| 2015 |
Brewer AJ, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ, Kosten TR, Newton TF, De La Garza R. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenetics and Genomics. 25: 296-304. PMID 25850966 DOI: 10.1097/Fpc.0000000000000137 |
0.632 |
|
| 2015 |
Sun Y, Zhao LY, Wang GB, Yue WH, He Y, Shu N, Lin QX, Wang F, Li JL, Chen N, Wang HM, Kosten TR, Feng JJ, Wang J, Tang Y, et al. ZNF804A variants confer risk for heroin addiction and affect decision making and gray matter volume in heroin abusers. Addiction Biology. PMID 25708696 DOI: 10.1111/Adb.12233 |
0.318 |
|
| 2015 |
Shorter D, Domingo CB, Kosten TR. Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy. Expert Opinion On Emerging Drugs. 20: 15-29. PMID 25425416 DOI: 10.1517/14728214.2015.985203 |
0.456 |
|
| 2015 |
Nielsen DA, Hamon S, Harding M, Nielsen EM, Kosten T, Newton TF, De La Garza R. Ubjective responses to acute cocaine are moderated by variants of the serotonergic system Drug and Alcohol Dependence. 156: e162-e163. DOI: 10.1016/J.Drugalcdep.2015.07.443 |
0.62 |
|
| 2015 |
Ma L, Steinberg JL, Cunningham KA, Lane SD, Bjork JM, Narayana P, Kosten T, Bechara A, Moeller FG. Inhibitory control: A brain connectivity study comparing cocaine-dependent subjects and controls Drug and Alcohol Dependence. 156: e137-e138. DOI: 10.1016/J.Drugalcdep.2015.07.376 |
0.383 |
|
| 2015 |
Schmitz J, Liu S, Green C, Lane SD, Kosten T, Gerard Moeller F, Nielsen DA. The influence of dopamine B-hydroxylase gene polymorphism −1021C Ç T on levodopa/carbidopa treatment for cocaine dependence: A preliminary study Drug and Alcohol Dependence. 146: e90. DOI: 10.1016/J.Drugalcdep.2014.09.613 |
0.603 |
|
| 2015 |
Nielsen DA, Walker R, Hamon S, Harding M, Ling W, Kosten T. Pharmacogenetics of buprenorphine therapy of cocaine addiction Drug and Alcohol Dependence. 146: e51-e52. DOI: 10.1016/J.Drugalcdep.2014.09.511 |
0.623 |
|
| 2015 |
Mancino MJ, Shervani S, Thostenson JD, Guise JB, McGaugh J, Kosten T, Oliveto A. Cognitive and cardiovascular effects of carvedilol in recently abstinent, cocaine-dependent patients Drug and Alcohol Dependence. 146: e191-e192. DOI: 10.1016/J.Drugalcdep.2014.09.436 |
0.402 |
|
| 2015 |
Li X, Shorter D, Kosten T. Prescription Opioid Misuse: Effective Methods for Reducing the Epidemic Current Treatment Options in Psychiatry. 2: 122-135. DOI: 10.1007/S40501-015-0045-6 |
0.353 |
|
| 2014 |
Kosten TA, Shen XY, Kinsey BM, Kosten TR, Orson FM. Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 604-7. PMID 25251469 DOI: 10.1111/J.1521-0391.2014.12152.X |
0.379 |
|
| 2014 |
Li X, Shorter D, Kosten TR. Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opinion On Pharmacotherapy. 15: 2263-75. PMID 25171726 DOI: 10.1517/14656566.2014.955469 |
0.369 |
|
| 2014 |
Graham DP, Nielsen DA, Kosten TR, Davis LL, Hamner MB, Makotkine I, Yehuda R. Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder. Psychiatric Genetics. 24: 181-2. PMID 24983834 DOI: 10.1097/Ypg.0000000000000039 |
0.553 |
|
| 2014 |
Orson FM, Wang R, Brimijoin S, Kinsey BM, Singh RA, Ramakrishnan M, Wang HY, Kosten TR. The future potential for cocaine vaccines. Expert Opinion On Biological Therapy. 14: 1271-83. PMID 24835496 DOI: 10.1517/14712598.2014.920319 |
0.411 |
|
| 2014 |
Liu S, Green CE, Lane SD, Kosten TR, Moeller FG, Nielsen DA, Schmitz JM. The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study. Pharmacogenetics and Genomics. 24: 370-3. PMID 24809448 DOI: 10.1097/Fpc.0000000000000055 |
0.624 |
|
| 2014 |
Ramakrishnan M, Kinsey BM, Singh RA, Kosten TR, Orson FM. Hapten optimization for cocaine vaccine with improved cocaine recognition. Chemical Biology & Drug Design. 84: 354-63. PMID 24803171 DOI: 10.1111/Cbdd.12326 |
0.412 |
|
| 2014 |
Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug and Alcohol Dependence. 140: 42-7. PMID 24793366 DOI: 10.1016/J.Drugalcdep.2014.04.003 |
0.366 |
|
| 2014 |
Spellicy CJ, Harding MJ, Hamon SC, Mahoney JJ, Reyes JA, Kosten TR, Newton TF, De La Garza R, Nielsen DA. A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. Genes, Brain, and Behavior. 13: 559-64. PMID 24528631 DOI: 10.1111/Gbb.12121 |
0.605 |
|
| 2014 |
Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. Journal of Clinical Psychopharmacology. 34: 234-9. PMID 24525654 DOI: 10.1097/Jcp.0000000000000062 |
0.442 |
|
| 2014 |
Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment. Drug and Alcohol Dependence. 136: 36-42. PMID 24462581 DOI: 10.1016/J.Drugalcdep.2013.12.007 |
0.473 |
|
| 2014 |
Kosten T, Domingo C, Orson F, Kinsey B. Vaccines against stimulants: cocaine and MA. British Journal of Clinical Pharmacology. 77: 368-74. PMID 23509915 DOI: 10.1111/Bcp.12115 |
0.385 |
|
| 2014 |
Verrico CD, Nielsen D, Spellicy C, Hamon S, Kosten T, Newton TF, Ii RDLG. Fatty acid amide hydrolase gene variant influences acute responses to cocaine Drug and Alcohol Dependence. 140: e234. DOI: 10.1016/J.Drugalcdep.2014.02.648 |
0.591 |
|
| 2014 |
Spellicy CJ, Nielsen DA, Hamon S, Kosten T, Harding M. Interaction of gender and genetics in response to cocaine vaccine Drug and Alcohol Dependence. 140: e214. DOI: 10.1016/J.Drugalcdep.2014.02.595 |
0.59 |
|
| 2014 |
Singh RA, Kinsey B, Huang Z, Kosten T, Orson F. Humanized mouse models to study effects of anti-cocaine vaccine Drug and Alcohol Dependence. 140: e210. DOI: 10.1016/J.Drugalcdep.2014.02.584 |
0.369 |
|
| 2014 |
Shutter TR, Shorter D, Nielsen DA, Kosten T. Attenuation of depressive symptoms associated with MTHFR during a cocaine vaccine trial Drug and Alcohol Dependence. 140: e207. DOI: 10.1016/J.Drugalcdep.2014.02.577 |
0.59 |
|
| 2014 |
Shorter D, Nielsen DA, Newton TF, De La Garza R, Kosten T. Association between α-1 adrenergic receptor (ADRA1A) genotype and subjective cocaine effect in cocaine-dependent individuals Drug and Alcohol Dependence. 140: e207. DOI: 10.1016/J.Drugalcdep.2014.02.575 |
0.631 |
|
| 2014 |
Oliveto A, Thostenson J, Kosten T, Mancino M. Mediators of response to sertraline vs. placebo among recently abstinent, cocaine-dependent patients Drug and Alcohol Dependence. 140: e165-e166. DOI: 10.1016/J.Drugalcdep.2014.02.466 |
0.438 |
|
| 2014 |
Nielsen DA, Spellicy C, Hamon S, Harding M, Mahoney JJ, Kosten T, De La Garza Ii R, Newton TF. Genetic variants of the dopaminergic system associated with subjective responses to cocaine Drug and Alcohol Dependence. 140: e161. DOI: 10.1016/J.Drugalcdep.2014.02.455 |
0.642 |
|
| 2014 |
Brewer A, Nielsen DA, Spellicy C, Hamon S, Gingrich J, Mahoney JJ, Kosten T, Newton TF, Garza RDL. Subjective effects produced by cocaine are in association with genetic variants of DAT1 Drug and Alcohol Dependence. 140: e19-e20. DOI: 10.1016/J.Drugalcdep.2014.02.075 |
0.621 |
|
| 2013 |
Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opinion On Investigational Drugs. 22: 1549-68. PMID 24033127 DOI: 10.1517/13543784.2013.836488 |
0.383 |
|
| 2013 |
Nielsen DA, Hamon SC, Kosten TR. The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial. Psychiatric Genetics. 23: 225-32. PMID 23995774 DOI: 10.1097/Ypg.0000000000000008 |
0.631 |
|
| 2013 |
Shorter D, Nielsen DA, Huang W, Harding MJ, Hamon SC, Kosten TR. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1401-7. PMID 23849431 DOI: 10.1016/J.Euroneuro.2013.05.014 |
0.656 |
|
| 2013 |
Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse. Pharmacogenetics and Genomics. 23: 333-40. PMID 23635803 DOI: 10.1097/Fpc.0B013E328361C39D |
0.645 |
|
| 2013 |
Kosten TR, Domingo CB. Can you vaccinate against substance abuse? Expert Opinion On Biological Therapy. 13: 1093-7. PMID 23594123 DOI: 10.1517/14712598.2013.791278 |
0.303 |
|
| 2013 |
Brimijoin S, Shen X, Orson F, Kosten T. Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse Expert Review of Vaccines. 12: 323-332. PMID 23496671 DOI: 10.1586/Erv.13.1 |
0.415 |
|
| 2013 |
Graham DP, Helmer DA, Harding MJ, Kosten TR, Petersen NJ, Nielsen DA. Serotonin transporter genotype and mild traumatic brain injury independently influence resilience and perception of limitations in veterans. Journal of Psychiatric Research. 47: 835-42. PMID 23478049 DOI: 10.1016/J.Jpsychires.2013.02.006 |
0.514 |
|
| 2013 |
Kosten TR, Domingo CB, Hamon SC, Nielsen DA. DBH gene as predictor of response in a cocaine vaccine clinical trial. Neuroscience Letters. 541: 29-33. PMID 23458673 DOI: 10.1016/J.Neulet.2013.02.037 |
0.637 |
|
| 2013 |
Orson FM, Rossen RD, Shen X, Lopez AY, Wu Y, Kosten TR. Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 169-74. PMID 23414504 DOI: 10.1111/J.1521-0391.2013.00314.X |
0.404 |
|
| 2013 |
Shorter D, Lindsay JA, Kosten TR. The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study. Drug and Alcohol Dependence. 131: 66-70. PMID 23306096 DOI: 10.1016/J.Drugalcdep.2012.11.021 |
0.453 |
|
| 2013 |
Brimijoin S, Orson F, Kosten TR, Kinsey B, Shen XY, White SJ, Gao Y. Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice. Chemico-Biological Interactions. 203: 212-6. PMID 22960160 DOI: 10.1016/J.Cbi.2012.08.015 |
0.449 |
|
| 2013 |
Gao Y, Geng L, Orson F, Kinsey B, Kosten TR, Shen X, Brimijoin S. Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage. Chemico-Biological Interactions. 203: 208-11. PMID 22935511 DOI: 10.1016/J.Cbi.2012.08.006 |
0.422 |
|
| 2013 |
Kosten TR, Wu G, Huang W, Harding MJ, Hamon SC, Lappalainen J, Nielsen DA. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase. Biological Psychiatry. 73: 219-24. PMID 22906516 DOI: 10.1016/J.Biopsych.2012.07.011 |
0.644 |
|
| 2013 |
Krupitsky E, Zvartau E, Blokhina E, Nielsen D, Kosten T, Woody G. P.6.d.004 Pharmacogenetics of treatment of opioid dependence with oral naltrexone and long acting sustained release naltrexone implant European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70916-7 |
0.53 |
|
| 2012 |
Spellicy CJ, Kosten TR, Hamon SC, Harding MJ, Nielsen DA. The MTHFR C677T Variant is Associated with Responsiveness to Disulfiram Treatment for Cocaine Dependency. Frontiers in Psychiatry. 3: 109. PMID 23335901 DOI: 10.3389/Fpsyt.2012.00109 |
0.643 |
|
| 2012 |
Haile CN, De La Garza R, Mahoney JJ, Nielsen DA, Kosten TR, Newton TF. The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. Plos One. 7: e47702. PMID 23144826 DOI: 10.1371/Journal.Pone.0047702 |
0.644 |
|
| 2012 |
Nielsen DA, Harding MJ, Hamon SC, Huang W, Kosten TR. Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study. Genes, Brain, and Behavior. 11: 1001-8. PMID 22925276 DOI: 10.1111/J.1601-183X.2012.00839.X |
0.635 |
|
| 2012 |
Carroll ME, Zlebnik NE, Anker JJ, Kosten TR, Orson FM, Shen X, Kinsey B, Parks RJ, Gao Y, Brimijoin S. Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion. Plos One. 7: e43536. PMID 22912888 DOI: 10.1371/Journal.Pone.0043536 |
0.447 |
|
| 2012 |
Nielsen DA, Utrankar A, Reyes JA, Simons DD, Kosten TR. Epigenetics of drug abuse: predisposition or response. Pharmacogenomics. 13: 1149-60. PMID 22909205 DOI: 10.2217/Pgs.12.94 |
0.552 |
|
| 2012 |
Ramakrishnan M, Alves De Melo F, Kinsey BM, Ladbury JE, Kosten TR, Orson FM. Probing cocaine-antibody interactions in buffer and human serum. Plos One. 7: e40518. PMID 22859949 DOI: 10.1371/Journal.Pone.0040518 |
0.378 |
|
| 2012 |
Zhang XY, Zhang WF, Zhou DF, Chen da C, Xiu MH, Wu HR, Haile CN, Kosten TA, Kosten TR. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba. Biological Psychiatry. 72: 700-6. PMID 22695185 DOI: 10.1016/J.Biopsych.2012.04.032 |
0.303 |
|
| 2012 |
Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. The American Journal of Drug and Alcohol Abuse. 38: 187-99. PMID 22404717 DOI: 10.3109/00952990.2011.653426 |
0.321 |
|
| 2012 |
Newton TF, De La Garza R, Brown G, Kosten TR, Mahoney JJ, Haile CN. Noradrenergic α₠receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. Plos One. 7: e30854. PMID 22319592 DOI: 10.1371/Journal.Pone.0030854 |
0.472 |
|
| 2012 |
Shen XY, Orson FM, Kosten TR. Vaccines against drug abuse. Clinical Pharmacology and Therapeutics. 91: 60-70. PMID 22130115 DOI: 10.1038/Clpt.2011.281 |
0.357 |
|
| 2012 |
Oliveto A, Poling J, Mancino MJ, Williams DK, Thostenson J, Pruzinsky R, Gonsai K, Sofuoglu M, Gonzalez G, Tripathi S, Kosten TR. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction (Abingdon, England). 107: 131-41. PMID 21707811 DOI: 10.1111/J.1360-0443.2011.03552.X |
0.433 |
|
| 2011 |
Shen X, Kosten TR. Immunotherapy for drug abuse. Cns & Neurological Disorders Drug Targets. 10: 876-9. PMID 22229313 DOI: 10.2174/187152711799219352 |
0.402 |
|
| 2011 |
Shorter D, Kosten TR. Novel pharmacotherapeutic treatments for cocaine addiction. Bmc Medicine. 9: 119. PMID 22047090 DOI: 10.1186/1741-7015-9-119 |
0.44 |
|
| 2011 |
Sofuoglu M, Mooney M, Kosten T, Waters A, Hashimoto K. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans Psychopharmacology. 213: 61-68. PMID 20838775 DOI: 10.1007/S00213-010-2014-5 |
0.325 |
|
| 2011 |
Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug and Alcohol Dependence. 113: 184-91. PMID 20828943 DOI: 10.1016/J.Drugalcdep.2010.07.022 |
0.467 |
|
| 2010 |
Kinsey BM, Kosten TR, Orson FM. Active immunotherapy for the Treatment of Cocaine Dependence. Drugs of the Future. 35: 301-306. PMID 21796226 DOI: 10.1358/Dof.2010.035.04.1474292 |
0.37 |
|
| 2010 |
Kinsey BM, Kosten TR, Orson FM. Anti-cocaine vaccine development. Expert Review of Vaccines. 9: 1109-14. PMID 20822352 DOI: 10.1586/Erv.10.102 |
0.411 |
|
| 2010 |
Oliveto A, Gentry WB, Pruzinsky R, Gonsai K, Kosten TR, Martell B, Poling J. Behavioral effects of gamma-hydroxybutyrate in humans. Behavioural Pharmacology. 21: 332-42. PMID 20526195 DOI: 10.1097/Fbp.0B013E32833B3397 |
0.305 |
|
| 2010 |
Gao Y, Orson FM, Kinsey B, Kosten T, Brimijoin S. The concept of pharmacologic cocaine interception as a treatment for drug abuse Chemico-Biological Interactions. 187: 421-424. PMID 20219449 DOI: 10.1016/J.Cbi.2010.02.036 |
0.437 |
|
| 2010 |
Stitzer ML, Polk T, Bowles S, Kosten T. Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives. Drug and Alcohol Dependence. 107: 76-9. PMID 19828264 DOI: 10.1016/J.Drugalcdep.2009.09.006 |
0.324 |
|
| 2010 |
Stine SM, Freeman M, Burns B, Charney DS, Kosten TR. Effect of Methadone Dose on Cocaine Abuse in a Methadone Program The American Journal On Addictions. 1: 294-303. DOI: 10.1111/J.1521-0391.1992.Tb00355.X |
0.442 |
|
| 2009 |
Castells X, Kosten TR, Capellà D, Vidal X, Colom J, Casas M. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials. The American Journal of Drug and Alcohol Abuse. 35: 339-49. PMID 20180662 DOI: 10.1080/00952990903108215 |
0.457 |
|
| 2009 |
Sofuoglu M, Poling J, Hill K, Kosten T. Atomoxetine attenuates dextroamphetamine effects in humans American Journal of Drug and Alcohol Abuse. 35: 412-416. PMID 20014909 DOI: 10.3109/00952990903383961 |
0.335 |
|
| 2009 |
Lu L, Wang X, Kosten TR. Stereotactic neurosurgical treatment of drug addiction. The American Journal of Drug and Alcohol Abuse. 35: 391-3. PMID 20014906 DOI: 10.3109/00952990903312478 |
0.304 |
|
| 2009 |
Haile CN, Kosten TR. The potential of pharmacogenomics to treat drug addiction. Pharmacogenomics. 10: 1883-6. PMID 19958085 DOI: 10.2217/Pgs.09.146 |
0.309 |
|
| 2009 |
Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Archives of General Psychiatry. 66: 1116-23. PMID 19805702 DOI: 10.1001/Archgenpsychiatry.2009.128 |
0.447 |
|
| 2009 |
Shi J, Li SX, Zhang XL, Wang X, Le Foll B, Zhang XY, Kosten TR, Lu L. Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts. The American Journal of Drug and Alcohol Abuse. 35: 267-72. PMID 19591065 DOI: 10.1080/00952990902933878 |
0.33 |
|
| 2009 |
Stotts AL, Dodrill CL, Kosten TR. Opioid dependence treatment: options in pharmacotherapy. Expert Opinion On Pharmacotherapy. 10: 1727-40. PMID 19538000 DOI: 10.1517/14656560903037168 |
0.325 |
|
| 2009 |
Shi J, Jun W, Zhao LY, Xue YX, Zhang XY, Kosten TR, Lu L. Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts. European Journal of Pharmacology. 615: 108-12. PMID 19470385 DOI: 10.1016/J.Ejphar.2009.05.011 |
0.332 |
|
| 2009 |
Haile CN, Kosten TR, Kosten TA. Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine. The American Journal of Drug and Alcohol Abuse. 35: 161-77. PMID 19462300 DOI: 10.1080/00952990902825447 |
0.451 |
|
| 2009 |
Orson FM, Kinsey BM, Singh RA, Wu Y, Kosten TR. Vaccines for cocaine abuse. Human Vaccines. 5: 194-9. PMID 19276665 DOI: 10.4161/Hv.5.4.7457 |
0.431 |
|
| 2009 |
Lu L, Liu Y, Zhu W, Shi J, Liu Y, Ling W, Kosten TR. Traditional medicine in the treatment of drug addiction. The American Journal of Drug and Alcohol Abuse. 35: 1-11. PMID 19152199 DOI: 10.1080/00952990802455469 |
0.328 |
|
| 2009 |
Ren ZY, Zhang XL, Liu Y, Zhao LY, Shi J, Bao Y, Zhang XY, Kosten TR, Lu L. Diurnal variation in cue-induced responses among protracted abstinent heroin users. Pharmacology, Biochemistry, and Behavior. 91: 468-72. PMID 18809427 DOI: 10.1016/J.Pbb.2008.08.023 |
0.32 |
|
| 2008 |
Orson FM, Kinsey BM, Singh RA, Wu Y, Gardner T, Kosten TR. Substance abuse vaccines. Annals of the New York Academy of Sciences. 1141: 257-69. PMID 18991962 DOI: 10.1196/Annals.1441.027 |
0.355 |
|
| 2008 |
Mooney ME, Poling J, Gonzalez G, Gonsai K, Kosten T, Sofuoglu M. Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 287-92. PMID 18612883 DOI: 10.1080/10550490802138814 |
0.406 |
|
| 2008 |
Haile CN, Kosten TA, Kosten TR. Pharmacogenetic treatments for drug addiction: alcohol and opiates. The American Journal of Drug and Alcohol Abuse. 34: 355-81. PMID 18584566 DOI: 10.1080/00952990802122564 |
0.327 |
|
| 2008 |
Sofuoglu M, Poling J, Waters A, Sewell A, Hill K, Kosten T. Disulfiram enhances subjective effects of dextroamphetamine in humans. Pharmacology, Biochemistry, and Behavior. 90: 394-8. PMID 18474395 DOI: 10.1016/J.Pbb.2008.03.021 |
0.385 |
|
| 2008 |
Li SX, Li J, Epstein DH, Zhang XY, Kosten TR, Lu L. Serum cortisol secretion during heroin abstinence is elevated only nocturnally. The American Journal of Drug and Alcohol Abuse. 34: 321-8. PMID 18428074 DOI: 10.1080/00952990802013664 |
0.302 |
|
| 2007 |
Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Oliveto A, Kosten TR. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Experimental and Clinical Psychopharmacology. 15: 453-60. PMID 17924779 DOI: 10.1037/1064-1297.15.5.453 |
0.441 |
|
| 2007 |
Orson FM, Kinsey BM, Singh RA, Wu Y, Gardner T, Kosten TR. The future of vaccines in the management of addictive disorders. Current Psychiatry Reports. 9: 381-7. PMID 17915077 DOI: 10.1007/S11920-007-0049-Z |
0.351 |
|
| 2007 |
Lane SD, Moeller FG, Steinberg JL, Buzby M, Kosten TR. Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty. The American Journal of Drug and Alcohol Abuse. 33: 717-26. PMID 17891664 DOI: 10.1080/00952990701522724 |
0.391 |
|
| 2007 |
Gardner T, Kosten T. Dual dependency on cocaine and alcohol in opiate addicts: treatment options. The Journal of Clinical Psychiatry. 68: 1142-3. PMID 17685754 DOI: 10.4088/Jcp.V68N0724 |
0.409 |
|
| 2007 |
Poling J, Pruzinsky R, Kosten TR, Gonsai K, Sofuoglu M, Gonzalez G, Oliveto A. Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 187-94. PMID 17612822 DOI: 10.1080/10550490701375640 |
0.344 |
|
| 2007 |
Poling J, Kosten TR, Sofuoglu M. Treatment outcome predictors for cocaine dependence. The American Journal of Drug and Alcohol Abuse. 33: 191-206. PMID 17497542 DOI: 10.1080/00952990701199416 |
0.469 |
|
| 2007 |
Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Annals of Internal Medicine. 146: 116-27. PMID 17227935 DOI: 10.7326/0003-4819-146-2-200701160-00006 |
0.317 |
|
| 2007 |
Sinha R, Kimmerling A, Doebrick C, Kosten TR. Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings. Psychopharmacology. 190: 569-74. PMID 17136399 DOI: 10.1007/S00213-006-0640-8 |
0.358 |
|
| 2007 |
Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Kosten T. Cocaine withdrawal symptoms predict medication response in cocaine users. The American Journal of Drug and Alcohol Abuse. 32: 617-27. PMID 17127550 DOI: 10.1080/00952990600920680 |
0.431 |
|
| 2007 |
Haile CN, Kosten TR, Kosten TA. Genetics of dopamine and its contribution to cocaine addiction. Behavior Genetics. 37: 119-45. PMID 17063402 DOI: 10.1007/S10519-006-9115-2 |
0.382 |
|
| 2007 |
González G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, Kosten TR. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug and Alcohol Dependence. 87: 1-9. PMID 16930857 DOI: 10.1016/J.Drugalcdep.2006.07.003 |
0.464 |
|
| 2006 |
Sofuoglu M, Kosten TR. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinion On Emerging Drugs. 11: 91-8. PMID 16503828 DOI: 10.1517/14728214.11.1.91 |
0.453 |
|
| 2006 |
Li CS, Kosten TR, Sinha R. Antisocial personality and stress-induced brain activation in cocaine-dependent patients. Neuroreport. 17: 243-7. PMID 16462591 DOI: 10.1097/01.Wnr.0000199471.06487.A2 |
0.384 |
|
| 2006 |
Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Archives of General Psychiatry. 63: 219-28. PMID 16461866 DOI: 10.1001/Archpsyc.63.2.219 |
0.46 |
|
| 2006 |
Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 644-50. PMID 16123763 DOI: 10.1038/Sj.Npp.1300851 |
0.442 |
|
| 2005 |
Sofuoglu M, Poling J, Mitchell E, Kosten TR. Tiagabine affects the subjective responses to cocaine in humans. Pharmacology, Biochemistry, and Behavior. 82: 569-73. PMID 16332385 DOI: 10.1016/J.Pbb.2005.10.013 |
0.45 |
|
| 2005 |
Kosten TR. What are America's opportunities for harm reduction strategies in opiate dependence? The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 14: 307-10. PMID 16188710 DOI: 10.1080/10550490591003530 |
0.322 |
|
| 2005 |
Sinha R, Lacadie C, Skudlarski P, Fulbright RK, Rounsaville BJ, Kosten TR, Wexler BE. Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology. 183: 171-80. PMID 16163517 DOI: 10.1007/S00213-005-0147-8 |
0.4 |
|
| 2005 |
Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biological Psychiatry. 58: 158-64. PMID 16038686 DOI: 10.1016/J.Biopsych.2005.04.032 |
0.425 |
|
| 2005 |
Kosten T, Owens SM. Immunotherapy for the treatment of drug abuse. Pharmacology & Therapeutics. 108: 76-85. PMID 16023218 DOI: 10.1016/J.Pharmthera.2005.06.009 |
0.366 |
|
| 2005 |
Abi-Saab D, Beauvais J, Mehm J, Brody M, Gottschalk C, Kosten TR. The effect of alcohol on the neuropsychological functioning of recently abstinent cocaine-dependent subjects. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 14: 166-78. PMID 16019965 DOI: 10.1080/10550490590924854 |
0.431 |
|
| 2005 |
Oliveto A, Poling J, Sevarino KA, Gonsai KR, McCance-Katz EF, Stine SM, Kosten TR. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug and Alcohol Dependence. 79: 157-65. PMID 16002025 DOI: 10.1016/J.Drugalcdep.2005.01.007 |
0.43 |
|
| 2005 |
McCance-Katz EF, Hart CL, Boyarsky B, Kosten T, Jatlow P. Gender effects following repeated administration of cocaine and alcohol in humans. Substance Use & Misuse. 40: 511-28. PMID 15830733 DOI: 10.1081/Ja-200030693 |
0.398 |
|
| 2005 |
Kosten T, Sofuoglu M, Poling J, Gonsai K, Oliveto A. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 14: 8-17. PMID 15804873 DOI: 10.1080/10550490590899817 |
0.45 |
|
| 2005 |
Li CS, Kosten TR, Sinha R. Sex differences in brain activation during stress imagery in abstinent cocaine users: a functional magnetic resonance imaging study. Biological Psychiatry. 57: 487-94. PMID 15737663 DOI: 10.1016/J.Biopsych.2004.11.048 |
0.383 |
|
| 2005 |
Boutros NN, Lisanby SH, McClain-Furmanski D, Oliwa G, Gooding D, Kosten TR. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. Journal of Psychiatric Research. 39: 295-302. PMID 15725428 DOI: 10.1016/J.Jpsychires.2004.07.002 |
0.422 |
|
| 2005 |
Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. The American Journal of Psychiatry. 162: 340-9. PMID 15677600 DOI: 10.1176/Appi.Ajp.162.2.340 |
0.445 |
|
| 2005 |
Sofuoglu M, Kosten TR. Novel approaches to the treatment of cocaine addiction. Cns Drugs. 19: 13-25. PMID 15651902 DOI: 10.2165/00023210-200519010-00002 |
0.455 |
|
| 2005 |
Poling J, Kosten TR. Risperidone for Substance Dependent Psychotic Patients Addictive Disorders & Their Treatment. 4: 1-3. DOI: 10.1097/00132576-200503000-00001 |
0.303 |
|
| 2005 |
Kosten TR. Advances in the pharmacotherapy of stimulant dependence: From alcohol antagonists to Xenova vaccines Clinical Neuroscience Research. 5: 169-173. DOI: 10.1016/J.Cnr.2005.08.013 |
0.45 |
|
| 2004 |
Sofuoglu M, Kosten TR. Pharmacologic management of relapse prevention in addictive disorders. The Psychiatric Clinics of North America. 27: 627-48. PMID 15550284 DOI: 10.1016/J.Psc.2004.06.002 |
0.378 |
|
| 2004 |
Tucker KA, Potenza MN, Beauvais JE, Browndyke JN, Gottschalk PC, Kosten TR. Perfusion abnormalities and decision making in cocaine dependence. Biological Psychiatry. 56: 527-30. PMID 15450790 DOI: 10.1016/J.Biopsych.2004.06.031 |
0.39 |
|
| 2004 |
Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR. Consensus statement on office-based treatment of opioid dependence using buprenorphine. Journal of Substance Abuse Treatment. 27: 153-9. PMID 15450648 DOI: 10.1016/J.Jsat.2004.06.005 |
0.331 |
|
| 2004 |
Sofuoglu M, Mitchell E, Kosten TR. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacology, Biochemistry, and Behavior. 78: 699-705. PMID 15301924 DOI: 10.1016/J.Pbb.2004.05.004 |
0.446 |
|
| 2004 |
West JC, Kosten TR, Wilk J, Svikis D, Triffleman E, Rae DS, Narrow WE, Duffy FF, Regier DA. Challenges in increasing access to buprenorphine treatment for opiate addiction. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 13: S8-16. PMID 15204672 DOI: 10.1080/10550490490440753 |
0.323 |
|
| 2004 |
Kosten T, Falcioni J, Oliveto A, Feingold A. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 13: 191-201. PMID 15204669 DOI: 10.1080/10550490490435966 |
0.35 |
|
| 2004 |
Oliveto A, Poling J, Kosten TR, Gonsai K. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure. European Journal of Pharmacology. 491: 157-68. PMID 15140632 DOI: 10.1016/J.Ejphar.2004.03.024 |
0.311 |
|
| 2004 |
Gonzalez G, Oliveto A, Kosten TR. Combating opiate dependence: a comparison among the available pharmacological options. Expert Opinion On Pharmacotherapy. 5: 713-25. PMID 15102558 DOI: 10.1517/14656566.5.4.713 |
0.352 |
|
| 2004 |
Browndyke JN, Tucker KA, Woods SP, Beauvals J, Cohen RA, Gottschalk PC, Kosten TR. Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusers. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 14: 162-9. PMID 15095563 DOI: 10.1111/J.1552-6569.2004.Tb00234.X |
0.412 |
|
| 2004 |
Tucker KA, Browndyke JN, Gottschalk PC, Cofrancesco AT, Kosten TR. Gender-specific vulnerability for rCBF abnormalities among cocaine abusers. Neuroreport. 15: 797-801. PMID 15073517 DOI: 10.1097/00001756-200404090-00011 |
0.437 |
|
| 2004 |
Haney M, Kosten TR. Therapeutic vaccines for substance dependence. Expert Review of Vaccines. 3: 11-8. PMID 14761239 DOI: 10.1016/J.Ddstr.2005.05.010 |
0.369 |
|
| 2003 |
Sofuoglu M, Gonzalez G, Poling J, Kosten TR. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. The American Journal of Drug and Alcohol Abuse. 29: 713-27. PMID 14713135 DOI: 10.1081/Ada-120026256 |
0.462 |
|
| 2003 |
Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction (Abingdon, England). 98: 1625-32. PMID 14616189 DOI: 10.1046/J.1360-0443.2003.00544.X |
0.458 |
|
| 2003 |
Haile CN, During MJ, Jatlow PI, Kosten TR, Kosten TA. Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats. Biological Psychiatry. 54: 915-21. PMID 14573319 DOI: 10.1016/S0006-3223(03)00241-5 |
0.429 |
|
| 2003 |
Gonzalez G, Feingold A, Oliveto A, Gonsai K, Kosten TR. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. The American Journal of Drug and Alcohol Abuse. 29: 497-514. PMID 14510037 DOI: 10.1081/Ada-120023455 |
0.39 |
|
| 2003 |
Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacology, Biochemistry, and Behavior. 75: 801-8. PMID 12957222 DOI: 10.1016/S0091-3057(03)00157-6 |
0.456 |
|
| 2003 |
Kosten TR, Gottschalk PC, Tucker K, Rinder CS, Dey HM, Rinder HM. Aspirin or amiloride for cerebral perfusion defects in cocaine dependence. Drug and Alcohol Dependence. 71: 187-94. PMID 12927657 DOI: 10.1016/S0376-8716(03)00132-7 |
0.353 |
|
| 2003 |
Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug and Alcohol Dependence. 70: 315-25. PMID 12757969 DOI: 10.1016/S0376-8716(03)00032-2 |
0.476 |
|
| 2003 |
Kosten T, Poling J, Oliveto A. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients. Addiction (Abingdon, England). 98: 665-71. PMID 12751984 DOI: 10.1046/J.1360-0443.2003.00380.X |
0.385 |
|
| 2003 |
Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. The New England Journal of Medicine. 348: 1786-95. PMID 12724485 DOI: 10.1056/Nejmra020617 |
0.352 |
|
| 2002 |
Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Science & Practice Perspectives / a Publication of the National Institute On Drug Abuse, National Institutes of Health. 1: 13-20. PMID 18567959 DOI: 10.1151/Spp021113 |
0.343 |
|
| 2002 |
Gottschalk PC, Kosten TR. Cerebral perfusion defects in combined cocaine and alcohol dependence. Drug and Alcohol Dependence. 68: 95-104. PMID 12167555 DOI: 10.1016/S0376-8716(02)00109-6 |
0.429 |
|
| 2002 |
Gonzalez G, Oliveto A, Kosten TR. Treatment of heroin (diamorphine) addiction: current approaches and future prospects. Drugs. 62: 1331-43. PMID 12076182 DOI: 10.2165/00003495-200262090-00004 |
0.356 |
|
| 2002 |
Feingold A, Oliveto A, Schottenfeld R, Kosten TR. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 11: 111-23. PMID 12028741 DOI: 10.1080/10550490290087884 |
0.42 |
|
| 2002 |
Boutros NN, Gelernter J, Gooding DC, Cubells J, Young A, Krystal JH, Kosten T. Sensory gating and psychosis vulnerability in cocaine-dependent individuals: preliminary data. Biological Psychiatry. 51: 683-6. PMID 11955469 DOI: 10.1016/S0006-3223(01)01237-9 |
0.425 |
|
| 2002 |
Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, Krystal JH. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biological Psychiatry. 51: 642-51. PMID 11955464 DOI: 10.1016/S0006-3223(01)01292-6 |
0.315 |
|
| 2002 |
Kosten TR, George TP, Kosten TA. The potential of dopamine agonists in drug addiction. Expert Opinion On Investigational Drugs. 11: 491-9. PMID 11922858 DOI: 10.1517/13543784.11.4.491 |
0.431 |
|
| 2002 |
Kosten TR, Oliveto A, Sevarino KA, Gonsai K, Feingold A. Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug and Alcohol Dependence. 66: 173-80. PMID 11906804 DOI: 10.1016/S0376-8716(01)00198-3 |
0.487 |
|
| 2002 |
Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Jack L, Fox B. Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine. 20: 1196-204. PMID 11803082 DOI: 10.1016/S0264-410X(01)00425-X |
0.357 |
|
| 2001 |
Fiellin DA, Rosenheck RA, Kosten TR. Office-based treatment for opioid dependence: reaching new patient populations. The American Journal of Psychiatry. 158: 1200-4. PMID 11481150 DOI: 10.1176/Appi.Ajp.158.8.1200 |
0.304 |
|
| 2001 |
Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. The American Journal of Psychiatry. 158: 1184-90. PMID 11481147 DOI: 10.1176/Appi.Ajp.158.8.1184 |
0.306 |
|
| 2001 |
Sernyak MJ, Kosten TR, Fontana A, Rosenheck R. Neuroleptic use in the treatment of Post-Traumatic Stress Disorder. The Psychiatric Quarterly. 72: 197-213. PMID 11467155 DOI: 10.1023/A:1010318414199 |
0.314 |
|
| 2001 |
McCance-Katz EF, Kosten TA, Kosten TR. Going from the bedside back to the bench with ecopipam: a new strategy for cocaine pharmacotherapy development. Psychopharmacology. 155: 327-9. PMID 11441421 DOI: 10.1007/S002130100745 |
0.412 |
|
| 2001 |
Oliveto A, McCance-Katz FE, Singha A, Petrakis I, Hameedi F, Kosten TR. Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers. Drug and Alcohol Dependence. 63: 155-67. PMID 11376920 DOI: 10.1016/S0376-8716(00)00198-8 |
0.45 |
|
| 2001 |
Stine SM, Grillon CG, Morgan CA, Kosten TR, Charney DS, Krystal JH. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology. 154: 274-81. PMID 11351934 DOI: 10.1007/S002130000644 |
0.351 |
|
| 2001 |
Petry NM, Petrakis I, Trevisan L, Wiredu G, Boutros NN, Martin B, Kosten TR. Contingency management interventions: from research to practice. The American Journal of Psychiatry. 158: 694-702. PMID 11329388 DOI: 10.1176/Appi.Ajp.158.5.694 |
0.375 |
|
| 2001 |
Gottschalk C, Beauvais J, Hart R, Kosten T. Cognitive function and cerebral perfusion during cocaine abstinence. The American Journal of Psychiatry. 158: 540-5. PMID 11282686 DOI: 10.1176/Appi.Ajp.158.4.540 |
0.412 |
|
| 2001 |
Boutros NN, Lisanby SH, Tokuno H, Torello MW, Campbell D, Berman R, Malison R, Krystal JH, Kosten T. Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation. Biological Psychiatry. 49: 369-73. PMID 11239908 DOI: 10.1016/S0006-3223(00)00948-3 |
0.391 |
|
| 2001 |
Jacobsen LK, Giedd JN, Gottschalk C, Kosten TR, Krystal JH. Quantitative morphology of the caudate and putamen in patients with cocaine dependence. The American Journal of Psychiatry. 158: 486-9. PMID 11229995 DOI: 10.1176/Appi.Ajp.158.3.486 |
0.441 |
|
| 2001 |
Jacobsen LK, Giedd JN, Kreek MJ, Gottschalk C, Kosten TR. Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary-adrenal axis function in cocaine dependence: a preliminary report. Drug and Alcohol Dependence. 62: 49-56. PMID 11173167 DOI: 10.1016/S0376-8716(00)00159-9 |
0.426 |
|
| 2000 |
Singha AK, McCance-Katz EF, Petrakis I, Kosten TR, Oliveto A. Sex differences in self-reported and physiological response to oral cocaine and placebo in humans. The American Journal of Drug and Alcohol Abuse. 26: 643-57. PMID 11097197 DOI: 10.1081/Ada-100101900 |
0.408 |
|
| 2000 |
Boutros N, Campbell D, Petrakis I, Krystal J, Caporale M, Kosten T. Cocaine use and the mid-latency auditory evoked responses Psychiatry Research. 96: 117-126. PMID 11063784 DOI: 10.1016/S0165-1781(00)00207-9 |
0.409 |
|
| 2000 |
Avants SK, Margolin A, Holford TR, Kosten TR. A randomized controlled trial of auricular acupuncture for cocaine dependence. Archives of Internal Medicine. 160: 2305-12. PMID 10927727 DOI: 10.1001/Archinte.160.15.2305 |
0.465 |
|
| 2000 |
Kosten TR, Fontana A, Sernyak MJ, Rosenheck R. Benzodiazepine use in posttraumatic stress disorder among veterans with substance abuse. The Journal of Nervous and Mental Disease. 188: 454-9. PMID 10919705 DOI: 10.1097/00005053-200007000-00010 |
0.343 |
|
| 2000 |
Sevarino KA, Oliveto A, Kosten TR. Neurobiological adaptations to psychostimulants and opiates as a basis of treatment development. Annals of the New York Academy of Sciences. 909: 51-87. PMID 10911924 DOI: 10.1111/J.1749-6632.2000.Tb06676.X |
0.454 |
|
| 2000 |
Farren CK, Hameedi FA, Rosen MA, Woods S, Jatlow P, Kosten TR. Significant interaction between clozapine and cocaine in cocaine addicts. Drug and Alcohol Dependence. 59: 153-63. PMID 10891628 DOI: 10.1016/S0376-8716(99)00114-3 |
0.459 |
|
| 2000 |
Jacobsen LK, Staley JK, Malison RT, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. The American Journal of Psychiatry. 157: 1134-40. PMID 10873923 DOI: 10.1176/Appi.Ajp.157.7.1134 |
0.411 |
|
| 2000 |
George TP, Chawarski MC, Pakes J, Carroll KM, Kosten TR, Schottenfeld RS. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biological Psychiatry. 47: 1080-6. PMID 10862808 DOI: 10.1016/S0006-3223(99)00310-8 |
0.458 |
|
| 2000 |
Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR. Thrice-weekly versus daily buprenorphine maintenance. Biological Psychiatry. 47: 1072-9. PMID 10862807 DOI: 10.1016/S0006-3223(99)00270-X |
0.337 |
|
| 2000 |
Winther LC, Saleem R, McCance-Katz EF, Rosen MI, Hameedi FA, Pearsall HR, Jatlow PI, Kosten TR, Woods SW. Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. The American Journal of Drug and Alcohol Abuse. 26: 47-59. PMID 10718163 DOI: 10.1081/ADA-100100590 |
0.327 |
|
| 2000 |
KOSTEN T. 704 Longitudinal safety and immunogenicity of a therapeutic cocaine vaccine Drug and Alcohol Dependence. 60: S250. DOI: 10.1016/S0376-8716(00)90007-3 |
0.364 |
|
| 2000 |
Boutros N, Torello M, Lisanby S, Campbell D, Kosten T. 456. Cortical excitability in cocaine-dependent subjects; preliminary data Biological Psychiatry. 47: S139. DOI: 10.1016/S0006-3223(00)00726-5 |
0.387 |
|
| 1999 |
Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. Archives of General Psychiatry. 56: 812-20. PMID 12884887 DOI: 10.1001/Archpsyc.56.9.812 |
0.449 |
|
| 1999 |
Gottschalk PC, Jacobsen LK, Kosten TR. Current concepts in pharmacotherapy of substance abuse. Current Psychiatry Reports. 1: 172-8. PMID 11122921 DOI: 10.1007/S11920-999-0028-7 |
0.393 |
|
| 1999 |
Singha AK, McCance-Katz EF, Heck SA, Kosten TR, Oliveto A. Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Experimental and Clinical Psychopharmacology. 7: 391-8. PMID 10609974 DOI: 10.1037//1064-1297.7.4.391 |
0.439 |
|
| 1999 |
Rosen MI, Kosten TR, Kreek MJ. The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers. Biological Psychiatry. 45: 1636-45. PMID 10376126 DOI: 10.1016/S0006-3223(98)00259-5 |
0.303 |
|
| 1999 |
Kosten TR, Woods SW, Rosen MI, Pearsall HR. Interactions of cocaine with nimodipine: a brief report. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 8: 77-81. PMID 10189518 DOI: 10.1080/105504999306117 |
0.326 |
|
| 1998 |
Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behavioural Pharmacology. 9: 207-17. PMID 9832935 |
0.315 |
|
| 1998 |
Rosen MI, Pearsall HR, Kosten TR. The effect of lamotrigine on naloxone-precipitated opiate withdrawal. Drug and Alcohol Dependence. 52: 173-6. PMID 9800147 DOI: 10.1016/S0376-8716(98)00057-X |
0.303 |
|
| 1998 |
McCance-Katz EF, Kosten TR, Jatlow P. Disulfiram effects on acute cocaine administration. Drug and Alcohol Dependence. 52: 27-39. PMID 9788003 DOI: 10.1016/S0376-8716(98)00050-7 |
0.462 |
|
| 1998 |
McCance-Katz EF, Kosten TR, Jatlow P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone--a multiple-dose study. Biological Psychiatry. 44: 250-9. PMID 9715356 DOI: 10.1016/S0006-3223(97)00426-5 |
0.441 |
|
| 1998 |
Malison RT, McCance E, Carpenter LL, Baldwin RM, Seibyl JP, Price LH, Kosten TR, Innis RB. [123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts. Psychopharmacology. 137: 321-5. PMID 9676890 DOI: 10.1007/S002130050625 |
0.357 |
|
| 1998 |
Petrakis I, Carroll KM, Nich C, Gordon L, Kosten T, Rounsaville B. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug and Alcohol Dependence. 50: 221-6. PMID 9649975 DOI: 10.1016/S0376-8716(98)00032-5 |
0.428 |
|
| 1998 |
Kosten TR, Cheeves C, Palumbo J, Seibyl JP, Price LH, Woods SW. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse. Drug and Alcohol Dependence. 50: 187-95. PMID 9649971 DOI: 10.1016/S0376-8716(98)00038-6 |
0.417 |
|
| 1998 |
Avants SK, Margolin A, DePhilippis D, Kosten TR. A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine- and opioid-dependent patients. Preliminary findings. Journal of Substance Abuse Treatment. 15: 261-5. PMID 9633038 DOI: 10.1016/S0740-5472(97)00226-2 |
0.41 |
|
| 1998 |
Malison RT, Best SE, van Dyck CH, McCance EF, Wallace EA, Laruelle M, Baldwin RM, Seibyl JP, Price LH, Kosten TR, Innis RB. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. The American Journal of Psychiatry. 155: 832-4. PMID 9619159 DOI: 10.1176/Ajp.155.6.832 |
0.394 |
|
| 1998 |
Oliveto AH, Rosen MI, Kosten TA, Hameedi FA, Woods SW, Kosten TR. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure. Experimental and Clinical Psychopharmacology. 6: 169-78. PMID 9608349 DOI: 10.1037//1064-1297.6.2.169 |
0.302 |
|
| 1998 |
McCance-Katz EF, Kosten TR, Jatlow P. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biological Psychiatry. 43: 540-3. PMID 9547934 DOI: 10.1016/S0006-3223(97)00506-4 |
0.458 |
|
| 1998 |
Kosten TR. Pharmacotherapy of cerebral ischemia in cocaine dependence. Drug and Alcohol Dependence. 49: 133-44. PMID 9543650 DOI: 10.1016/S0376-8716(97)00158-0 |
0.42 |
|
| 1998 |
Bowers MB, Malison RT, Seibyl JP, Kosten TR. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. Biological Psychiatry. 43: 278-81. PMID 9513737 DOI: 10.1016/S0006-3223(97)00293-X |
0.349 |
|
| 1998 |
Margolin A, Avants SK, DePhilippis D, Kosten TR. A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. The American Journal of Drug and Alcohol Abuse. 24: 85-101. PMID 9513631 |
0.335 |
|
| 1998 |
Markou A, Kosten TR, Koob GF. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 135-74. PMID 9471114 DOI: 10.1016/S0893-133X(97)00113-9 |
0.315 |
|
| 1998 |
Schottenfeld RS, Pakes JR, Kosten TR. Prognostic factors in Buprenorphine- versus methadone-maintained patients. The Journal of Nervous and Mental Disease. 186: 35-43. PMID 9457145 DOI: 10.1097/00005053-199801000-00006 |
0.396 |
|
| 1998 |
O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. Jama. 279: 229-34. PMID 9438745 DOI: 10.1001/Jama.279.3.229 |
0.307 |
|
| 1997 |
Avants SK, Margolin A, McMahon TJ, Kosten TR. Association between self-report of cognitive impairment, HIV status, and cocaine use in a sample of cocaine-dependent methadone-maintained patients. Addictive Behaviors. 22: 599-611. PMID 9347062 DOI: 10.1016/S0306-4603(96)00070-6 |
0.404 |
|
| 1997 |
O'Connor PG, Carroll KM, Shi JM, Schottenfeld RS, Kosten TR, Rounsaville BJ. Three methods of opioid detoxification in a primary care setting. A randomized trial. Annals of Internal Medicine. 127: 526-30. PMID 9313020 DOI: 10.7326/0003-4819-127-7-199710010-00004 |
0.343 |
|
| 1997 |
Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry. 54: 713-20. PMID 9283506 DOI: 10.1001/Archpsyc.1997.01830200041006 |
0.435 |
|
| 1997 |
Rosen MI, Pearsall HR, Woods SW, Kosten TR. Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients. Journal of Substance Abuse Treatment. 14: 149-54. PMID 9258859 DOI: 10.1016/S0740-5472(96)00157-2 |
0.313 |
|
| 1997 |
Margolin A, Avants SK, Rounsaville B, Kosten TR, Schottenfeld RS. Motivational factors in cocaine pharmacotherapy trials with methadone-maintained patients: problems and paradoxes. Journal of Psychoactive Drugs. 29: 205-12. PMID 9250948 DOI: 10.1080/02791072.1997.10400189 |
0.445 |
|
| 1997 |
Stine SM, Krystal JH, Petrakis IL, Jatlow PI, Heninger GR, Kosten TR, Charney DS. Effect of alpha-methyl-para-tyrosine on response to cocaine challenge. Biological Psychiatry. 42: 181-90. PMID 9232210 DOI: 10.1016/S0006-3223(96)00331-9 |
0.443 |
|
| 1997 |
Warner EA, Kosten TR, O'Connor PG. Pharmacotherapy for opioid and cocaine abuse. The Medical Clinics of North America. 81: 909-25. PMID 9222260 DOI: 10.1016/S0025-7125(05)70555-1 |
0.383 |
|
| 1997 |
Kosten TR, Ziedonis DM. Substance abuse and schizophrenia: editors' introduction. Schizophrenia Bulletin. 23: 181-6. PMID 9165628 DOI: 10.1093/Schbul/23.2.181 |
0.37 |
|
| 1997 |
Silverman DG, Kosten TR, Jatlow PI, Gutter V, Fleming J, O'Connor TZ, Byck R. Decreased digital flow persists after the abatement of cocaine-induced hemodynamic stimulation. Anesthesia and Analgesia. 84: 46-50. PMID 8988997 DOI: 10.1097/00000539-199701000-00008 |
0.413 |
|
| 1997 |
Margolin A, Avants SK, Malison RT, Kosten TR. High‐ and low‐dose Mazindol for cocaine dependence in methadone‐maintained patients: A preliminary evaluation Substance Abuse. 18: 125-131. DOI: 10.1080/08897079709511358 |
0.311 |
|
| 1997 |
Kosten TA, Kosten TR. Chapter 51 The dependence syndrome concept for alcohol and drug abuse Principles of Medical Biology. 8: 995-1002. DOI: 10.1016/S1569-2582(97)80112-2 |
0.303 |
|
| 1996 |
Wallace EA, Wisniewski G, Zubal G, vanDyck CH, Pfau SE, Smith EO, Rosen MI, Sullivan MC, Woods SW, Kosten TR. Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology. 128: 17-20. PMID 8944401 DOI: 10.1007/S002130050104 |
0.396 |
|
| 1996 |
O'Connor PG, Oliveto AH, Shi JM, Triffleman E, Carroll KM, Kosten TR, Rounsaville BJ. A pilot study of primary-care-based buprenorphine maintenance for heroin dependence. The American Journal of Drug and Alcohol Abuse. 22: 523-31. PMID 8911590 DOI: 10.3109/00952999609001678 |
0.313 |
|
| 1996 |
Margolin A, Avants SK, Kosten TR. Pemoline for the treatment of cocaine dependence in methadone-maintained patients. Journal of Psychoactive Drugs. 28: 301-4. PMID 8895115 DOI: 10.1080/02791072.1996.10472491 |
0.344 |
|
| 1996 |
Rosen MI, Pearsall HR, Woods SW, Kosten TR. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 14: 187-93. PMID 8866702 DOI: 10.1016/0893-133X(95)00087-T |
0.332 |
|
| 1996 |
Margolin A, Avants SK, Kosten TR. Abstinence symptomatology associated with cessation of chronic cocaine abuse among methadone-maintained patients. The American Journal of Drug and Alcohol Abuse. 22: 377-88. PMID 8841686 DOI: 10.3109/00952999609001666 |
0.446 |
|
| 1996 |
Rosen MI, McMahon TJ, Woods SW, Pearsall HR, Kosten TR. A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal. European Journal of Pharmacology. 307: 251-7. PMID 8836612 DOI: 10.1016/0014-2999(96)00249-X |
0.303 |
|
| 1996 |
Hameedi FA, Sernyak MJ, Navui SA, Kosten TR. Near syncope associated with concomitant clozapine and cocaine use. The Journal of Clinical Psychiatry. 57: 371-2. PMID 8752022 |
0.32 |
|
| 1996 |
Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, Oliveto AH, Price LH. Gender differences in response to intranasal cocaine administration to humans. Biological Psychiatry. 39: 147-8. PMID 8717615 DOI: 10.1016/0006-3223(95)00386-X |
0.417 |
|
| 1996 |
Margolin A, Avants SK, Kosten TR. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients. The American Journal of Drug and Alcohol Abuse. 21: 469-81. PMID 8561098 DOI: 10.3109/00952999509002711 |
0.366 |
|
| 1996 |
Kosten TR, McCance E. A Review of Pharmacotherapie for Substance Abuse American Journal On Addictions. 5: 58-65. DOI: 10.3109/10550499608995657 |
0.406 |
|
| 1996 |
Best SE, Oliveto AH, Kosten TR. Opioid Addiction Cns Drugs. 6: 301-314. DOI: 10.2165/00023210-199606040-00005 |
0.317 |
|
| 1996 |
Petrakis IL, Satel SL, Stine S, Kosten TR, Namanworth SN, Charney DS, Krystal JH. AMPT Effects on Cue-Induced Craving for Cocaine The American Journal On Addictions. 5: 313-320. DOI: 10.1111/J.1521-0391.1996.Tb00317.X |
0.42 |
|
| 1996 |
Margolin A, Avants SK, Falcioni J, Kosten TR. Preliminary Investigation of Selegiline for the Treatment of Cocaine Dependence The American Journal On Addictions. 5: 275-276. DOI: 10.1111/J.1521-0391.1996.Tb00311.X |
0.442 |
|
| 1996 |
Avants SK, Margolin A, Kosten TR. Influence of treatment readiness on outcomes of two pharmacotherapy trials for cocaine abuse among methadone-maintained patients. Psychology of Addictive Behaviors. 10: 147-156. DOI: 10.1037/0893-164X.10.3.147 |
0.437 |
|
| 1995 |
Oliveto A, Kosten TR, Schottenfeld R, Falcioni J, Ziedonis D. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. Journal of Substance Abuse Treatment. 12: 423-8. PMID 8749726 DOI: 10.1016/0740-5472(95)02015-2 |
0.451 |
|
| 1995 |
Margolin A, Kosten TR, Avants SK, Wilkins J, Ling W, Beckson M, Arndt IO, Cornish J, Ascher JA, Li SH, Bridge P. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients Drug and Alcohol Dependence. 40: 125-131. PMID 8745134 DOI: 10.1016/0376-8716(95)01198-6 |
0.446 |
|
| 1995 |
Stine SM, Krystal JH, Kosten TR, Charney DS. Mazindol treatment for cocaine dependence Drug and Alcohol Dependence. 39: 245-252. PMID 8556974 DOI: 10.1016/0376-8716(95)01174-4 |
0.417 |
|
| 1995 |
Margolin A, Avants SK, Kosten TR. Cue-elicited cocaine craving and autogenic relaxation. Association with treatment outcome. Journal of Substance Abuse Treatment. 11: 549-52. PMID 7884838 DOI: 10.1016/0740-5472(94)90006-X |
0.424 |
|
| 1995 |
Meandzija B, O'Connor PG, Fitzgerald B, Rounsaville BJ, Kosten TR. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug and Alcohol Dependence. 36: 109-13. PMID 7851277 DOI: 10.1016/0376-8716(94)90092-2 |
0.371 |
|
| 1995 |
Stine SM, Kosten TR. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance. The American Journal of Drug and Alcohol Abuse. 20: 445-58. PMID 7832179 DOI: 10.3109/00952999409109183 |
0.452 |
|
| 1995 |
Krystal JH, Woods SW, Kosten TR, Rosen MI, Seibyl JP, van Dyck CC, Price LH, Zubal IG, Hoffer PB, Charney DS. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). The American Journal of Drug and Alcohol Abuse. 21: 47-63. PMID 7762544 DOI: 10.3109/00952999509095229 |
0.309 |
|
| 1995 |
Satel SL, Krystal JH, Delgado PL, Kosten TR, Charney DS. Tryptophan depletion and attenuation of cue-induced craving for cocaine. The American Journal of Psychiatry. 152: 778-83. PMID 7726319 DOI: 10.1176/Ajp.152.5.778 |
0.396 |
|
| 1995 |
Kosten TR, Rayford BS. Effects of ethnicity on low-dose opiate stabilization. Journal of Substance Abuse Treatment. 12: 111-6. PMID 7623388 DOI: 10.1016/0740-5472(94)00069-4 |
0.305 |
|
| 1995 |
Hameedi FA, Rosen MI, McCance-Katz EF, McMahon TJ, Price LH, Jatlow PI, Woods SW, Kosten TR. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans Biological Psychiatry. 37: 560-563. PMID 7619981 DOI: 10.1016/0006-3223(94)00361-6 |
0.388 |
|
| 1995 |
Avants SK, Margolin A, Kosten TR, Cooney NL. Differences between responders and nonresponders to cocaine cues in the laboratory. Addictive Behaviors. 20: 215-24. PMID 7484315 DOI: 10.1016/0306-4603(94)00066-2 |
0.444 |
|
| 1995 |
Avants SK, Margolin A, Chang P, Kosten TR, Birch S. Acupuncture for the treatment of cocaine addiction. Investigation of a needle puncture control. Journal of Substance Abuse Treatment. 12: 195-205. PMID 7474027 DOI: 10.1016/0740-5472(95)00014-V |
0.404 |
|
| 1995 |
Rao S, Ziedonis D, Kosten T. The Pharmacotherapy of Cocaine Dependence Psychiatric Annals. 25: 363-368. DOI: 10.3928/0048-5713-19950601-08 |
0.434 |
|
| 1994 |
Avants SK, Margolin A, Kosten TR, Singer JL. Changes concurrent with initiation of abstinence from cocaine abuse. Journal of Substance Abuse Treatment. 10: 577-83. PMID 8308943 DOI: 10.1016/0740-5472(93)90062-7 |
0.445 |
|
| 1994 |
Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug and Alcohol Dependence. 35: 31-5. PMID 8082553 DOI: 10.1016/0376-8716(94)90107-4 |
0.448 |
|
| 1994 |
McDougle CJ, Black JE, Malison RT, Zimmermann RC, Kosten TR, Heninger GR, Price LH. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Archives of General Psychiatry. 51: 713-9. PMID 8080348 DOI: 10.1001/Archpsyc.1994.03950090045007 |
0.441 |
|
| 1994 |
Avants SK, Margolin A, Kosten TR. Cocaine abuse in methadone maintenance programs: integrating pharmacotherapy with psychosocial interventions. Journal of Psychoactive Drugs. 26: 137-46. PMID 7931858 DOI: 10.1080/02791072.1994.10472261 |
0.459 |
|
| 1994 |
Rinder HM, Ault KA, Jatlow PI, Kosten TR, Smith BR. Platelet alpha-granule release in cocaine users. Circulation. 90: 1162-7. PMID 7522132 DOI: 10.1161/01.Cir.90.3.1162 |
0.31 |
|
| 1994 |
Oliveto AH, Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Cocaine Use in Buprenorphine- vs. Methadone-Maintained Patients The American Journal On Addictions. 3: 43-48. DOI: 10.1111/J.1521-0391.1994.Tb00225.X |
0.455 |
|
| 1994 |
Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Comparing Buprenorphine and Methadone Maintenance The Journal of Nervous and Mental Disease. 182: 246. DOI: 10.1097/00005053-199404000-00015 |
0.327 |
|
| 1993 |
Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. The Journal of Nervous and Mental Disease. 181: 358-64. PMID 8501457 DOI: 10.1097/00005053-199306000-00004 |
0.324 |
|
| 1993 |
Kosten TA, Gawin FH, Kosten TR, Rounsaville BJ. Gender differences in cocaine use and treatment response Journal of Substance Abuse Treatment. 10: 63-66. PMID 8450576 DOI: 10.1016/0740-5472(93)90100-G |
0.422 |
|
| 1993 |
Schottenfeld RS, Pakes J, Ziedonis D, Kosten TR. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biological Psychiatry. 34: 66-74. PMID 8373940 DOI: 10.1016/0006-3223(93)90258-F |
0.409 |
|
| 1993 |
Rosen MI, Pearsall HR, Mcdougle CJ, Price LH, Woods SW, Kosten TR. Effects of acute buprenorphine on responses to intranasal cocaine: A pilot study American Journal of Drug and Alcohol Abuse. 19: 451-464. PMID 8273766 DOI: 10.3109/00952999309001634 |
0.44 |
|
| 1993 |
Oliveto A, Kosten T, Schottenfeld R, Ziedonis D. Cocaine abuse among methadone-maintained patients. The American Journal of Psychiatry. 150: 1755. PMID 8214197 DOI: 10.1176/Ajp.150.11.1755A |
0.445 |
|
| 1993 |
Satel SL, Kosten TR, Schuckit MA, Fischman MW. Should protracted withdrawal from drugs be included in DSM-IV? The American Journal of Psychiatry. 150: 695-704. PMID 8097618 DOI: 10.1176/Ajp.150.5.695 |
0.344 |
|
| 1993 |
McCance-Katz EF, Price LH, McDougle CJ, Kosten TR, Black JE, Jatlow PI. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology. 111: 39-46. PMID 7870932 DOI: 10.1007/Bf02257405 |
0.414 |
|
| 1993 |
Stine SM, Satel S, Kosten T. Cocaine Precipitation of Patient-Identified Opiate Withdrawal The American Journal On Addictions. 2: 255-258. DOI: 10.1111/J.1521-0391.1993.Tb00428.X |
0.447 |
|
| 1993 |
Margolin A, Avants SK, Chang P, Kosten TR. Acupuncture for the Treatment of Cocaine Dependence in Methadone-Maintained Patients The American Journal On Addictions. 2: 194-201. DOI: 10.1111/J.1521-0391.1993.Tb00419.X |
0.461 |
|
| 1993 |
Kosten TR, Steinberg M, Diakogiannis IA. Crossover Trial of Mazindol for Cocaine Dependence The American Journal On Addictions. 2: 161-164. DOI: 10.1111/J.1521-0391.1993.Tb00216.X |
0.452 |
|
| 1992 |
Ziedonis DM, Kosten TR. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. Journal of Psychoactive Drugs. 23: 417-25. PMID 1813613 DOI: 10.1080/02791072.1991.10471612 |
0.416 |
|
| 1992 |
Kosten TA, Bianchi MS, Kosten TR. The predictive validity of the dependence syndrome in opiate abusers American Journal of Drug and Alcohol Abuse. 18: 145-156. PMID 1562012 DOI: 10.3109/00952999208992827 |
0.349 |
|
| 1992 |
Kosten TR. Pharmacological approaches to cocaine dependence. Clinical Neuropharmacology. 70A-71A. PMID 1498999 DOI: 10.1097/00002826-199201001-00038 |
0.421 |
|
| 1992 |
Kosten T, Silverman DG, Fleming J, Kosten TA, Gawin FH, Compton M, Jatlow P, Byck R. Intravenous cocaine challenges during naltrexone maintenance: A preliminary study Biological Psychiatry. 32: 543-548. PMID 1445971 DOI: 10.1016/0006-3223(92)90223-M |
0.408 |
|
| 1992 |
Kosten TR, Morgan C, Kreek MJ. Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: preliminary findings. Biological Psychiatry. 32: 523-8. PMID 1445968 DOI: 10.1016/0006-3223(92)90220-T |
0.315 |
|
| 1992 |
Kosten TR, Morgan CM, Falcione J, Schottenfeld RS. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Archives of General Psychiatry. 49: 894-8. PMID 1444728 DOI: 10.1001/Archpsyc.1992.01820110058009 |
0.461 |
|
| 1992 |
Rosen MI, Wallace EA, Sullivan MC, Stine S, Kosten TR. Use of cocaine to prevent opiate withdrawal. The American Journal of Psychiatry. 149: 1609. PMID 1415835 DOI: 10.1176/ajp.149.11.1609b |
0.332 |
|
| 1992 |
Nigam R, Schottenfeld R, Kosten TR. Treatment of dual diagnosis patients: a relapse prevention group approach. Journal of Substance Abuse Treatment. 9: 305-9. PMID 1362227 DOI: 10.1016/0740-5472(92)90023-H |
0.387 |
|
| 1992 |
McDougle CJ, Price LH, Palumbo JM, Kosten TR, Heninger GR, Kleber HD. Dopaminergic responsivity during cocaine abstinence: a pilot study. Psychiatry Research. 43: 77-85. PMID 1359594 DOI: 10.1016/0165-1781(92)90143-Q |
0.44 |
|
| 1992 |
Krystal JH, McDougle CJ, Kosten TR, Price LH, Aghajanian GK, Charney DS. Baclofen-assisted detoxification from opiates. A pilot study. Journal of Substance Abuse Treatment. 9: 139-42. PMID 1324986 DOI: 10.1016/0740-5472(92)90081-X |
0.314 |
|
| 1992 |
Rosen MI, Kosten T. Cocaine-associated panic attacks in methadone-maintained patients. The American Journal of Drug and Alcohol Abuse. 18: 57-62. PMID 1314016 DOI: 10.3109/00952999209001611 |
0.441 |
|
| 1992 |
Kosten TR. Can Cocaine Craving Be a Medication Development Outcome?: Drug Craving and Relapse in Opioid and Cocaine Dependence American Journal On Addictions. 1: 230-239. DOI: 10.3109/10550499209004025 |
0.473 |
|
| 1992 |
Kosten TA, Kosten TR, Gawin FH, Gordon LT, Hogan I, Kleber HD. An Open Trial of Sertraline for Cocaine Abuse The American Journal On Addictions. 1: 349-353. DOI: 10.1111/J.1521-0391.1992.Tb00361.X |
0.458 |
|
| 1992 |
Kosten TR, Gawin FH, Kosten TA, Morgan C, Rounsaville BJ, Schottenfeld R, Kleber HD. Six-Month Follow-Up of Short-Term Pharmacotherapy for Cocaine Dependence The American Journal On Addictions. 1: 40-49. DOI: 10.1111/J.1521-0391.1992.Tb00005.X |
0.338 |
|
| 1992 |
Kosten TR. Drugs for Cocaine Dependence: Not Easy-Reply Archives of General Psychiatry. 49: 905. DOI: 10.1001/Archpsyc.1992.01820110069012 |
0.454 |
|
| 1991 |
Kosten TR, Gawin FH, Morgan C, Nelson JC, Jatlow P. Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse. The American Journal of Drug and Alcohol Abuse. 16: 329-36. PMID 2288330 DOI: 10.3109/00952999009001594 |
0.318 |
|
| 1991 |
O'Malley SS, Kosten TR, Renner JA. Dual diagnoses: substance abuse and personality disorders. New Directions For Mental Health Services. 115-37. PMID 2277608 DOI: 10.1002/Yd.23319904709 |
0.322 |
|
| 1991 |
Rosen MI, Kosten TR. Buprenorphine: beyond methadone? Hospital & Community Psychiatry. 42: 347-9. PMID 2050347 DOI: 10.1176/Ps.42.4.347 |
0.397 |
|
| 1991 |
Rounsaville BJ, Kosten TR, Weissman MM, Prusoff B, Pauls D, Anton SF, Merikangas K. Psychiatric disorders in relatives of probands with opiate addiction. Archives of General Psychiatry. 48: 33-42. PMID 1984760 DOI: 10.1001/Archpsyc.1991.01810250035004 |
0.336 |
|
| 1991 |
Kosten TA, Kosten TR. Pharmacological blocking agents for treating substance abuse Journal of Nervous and Mental Disease. 179: 583-592. PMID 1919542 DOI: 10.1097/00005053-199110000-00001 |
0.304 |
|
| 1991 |
Margolin A, Kosten T, Petrakis I, Avants SK, Kosten T. Bupropion Reduces Cocaine Abuse in Methadone-Maintained Patients Archives of General Psychiatry. 48: 87-87. PMID 1898631 DOI: 10.1001/Archpsyc.1991.01810250089015 |
0.448 |
|
| 1991 |
Stine SM, Burns B, Kosten T. Methadone dose for cocaine abuse. The American Journal of Psychiatry. 148: 1268. PMID 1883015 DOI: 10.1176/ajp.148.9.1268a |
0.314 |
|
| 1991 |
Kosten TR, Morgan C, Kleber HD. Treatment of heroin addicts using buprenorphine. The American Journal of Drug and Alcohol Abuse. 17: 119-28. PMID 1862786 DOI: 10.3109/00952999108992815 |
0.36 |
|
| 1990 |
Jacobsen LK, Kosten TR. Naloxone challenge as a biological predictor of treatment outcome in opiate addicts. The American Journal of Drug and Alcohol Abuse. 15: 355-66. PMID 2596440 DOI: 10.3109/00952998908992796 |
0.301 |
|
| 1990 |
Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD. Opioid antagonist challenges in buprenorphine maintained patients. Drug and Alcohol Dependence. 25: 73-8. PMID 2323312 DOI: 10.1016/0376-8716(90)90144-4 |
0.324 |
|
| 1990 |
Kosten TR, Morgan C, Kosten TA. Depressive symptoms during buprenorphine treatment of opioid abusers Journal of Substance Abuse Treatment. 7: 51-54. PMID 2313769 DOI: 10.1016/0740-5472(90)90035-O |
0.318 |
|
| 1990 |
Kosten TR. Neurobiology of abused drugs. Opioids and stimulants. The Journal of Nervous and Mental Disease. 178: 217-27. PMID 2156952 DOI: 10.1097/00005053-199004000-00001 |
0.344 |
|
| 1990 |
Kosten T, Margolin A. New Developments in Opioid Abuse Treatment Annals of Clinical Psychiatry. 2: 245-250. DOI: 10.3109/10401239009147952 |
0.323 |
|
| 1989 |
Kosten TR, Kleber HD, Morgan C. Role of opioid antagonists in treating intravenous cocaine abuse. Life Sciences. 44: 887-92. PMID 2927249 DOI: 10.1016/0024-3205(89)90589-4 |
0.443 |
|
| 1989 |
Kosten TA, Kosten TR, Rounsaville BJ. Personality disorders in opiate addicts show prognostic specificity Journal of Substance Abuse Treatment. 6: 163-168. PMID 2795705 DOI: 10.1016/0740-5472(89)90003-2 |
0.311 |
|
| 1989 |
Kosten TR, Kleber HD, Morgan C. Treatment of cocaine abuse with buprenorphine. Biological Psychiatry. 26: 637-9. PMID 2790101 DOI: 10.1016/0006-3223(89)90090-5 |
0.459 |
|
| 1989 |
Kosten TA, Jacobsen LK, Kosten TR. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria American Journal of Drug and Alcohol Abuse. 15: 237-250. PMID 2763981 DOI: 10.3109/00952998908993405 |
0.329 |
|
| 1989 |
Kosten TR. Pharmacotherapeutic interventions for cocaine abuse. Matching patients to treatments. The Journal of Nervous and Mental Disease. 177: 379-89. PMID 2664072 DOI: 10.1097/00005053-198907000-00001 |
0.445 |
|
| 1989 |
Berger P, Gawin F, Kosten TR. Treatment of cocaine abuse with mazindol. Lancet (London, England). 1: 283. PMID 2563451 DOI: 10.1016/S0140-6736(89)91299-3 |
0.336 |
|
| 1989 |
Gawin FH, Morgan C, Kosten TR, Kleber HD. Double-blind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology. 97: 402-3. PMID 2497490 DOI: 10.1007/Bf00439458 |
0.451 |
|
| 1989 |
Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C. Desipramine facilitation of initial cocaine abstinence. Archives of General Psychiatry. 46: 117-21. PMID 2492422 DOI: 10.1001/Archpsyc.1989.01810020019004 |
0.463 |
|
| 1988 |
Kosten TR, Schumann B, Wright D. Bromocriptine treatment of cocaine abuse in patients maintained on methadone. The American Journal of Psychiatry. 145: 381-2. PMID 3344859 DOI: 10.1176/ajp.145.3.381b |
0.346 |
|
| 1988 |
Kosten TR, Rounsaville BJ, Kleber HD. Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up. The Journal of Nervous and Mental Disease. 176: 176-81. PMID 3343591 DOI: 10.1097/00005053-198803000-00006 |
0.47 |
|
| 1988 |
Mason JW, Giller EL, Kosten TR. Serum testosterone differences between patients with schizophrenia and those with affective disorder. Biological Psychiatry. 23: 357-66. PMID 3342266 DOI: 10.1016/0006-3223(88)90286-7 |
0.303 |
|
| 1988 |
Kosten TR, Kleber HD. Buprenorphine detoxification from opioid dependence: a pilot study. Life Sciences. 42: 635-41. PMID 3276999 DOI: 10.1016/0024-3205(88)90454-7 |
0.333 |
|
| 1988 |
Kosten TR, Kleber HD. Differential diagnosis of psychiatric comorbidity in substance abusers. Journal of Substance Abuse Treatment. 5: 201-6. PMID 3216436 DOI: 10.1016/0740-5472(88)90042-6 |
0.324 |
|
| 1988 |
Kosten TR, Rounsaville BJ. Suicidality among opioid addicts: 2.5 year follow-up. The American Journal of Drug and Alcohol Abuse. 14: 357-69. PMID 3189257 DOI: 10.3109/00952998809001557 |
0.3 |
|
| 1988 |
Kosten TR, Kleber HD. Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome? The American Journal of Drug and Alcohol Abuse. 14: 335-46. PMID 3055940 DOI: 10.3109/00952998809001555 |
0.406 |
|
| 1988 |
Kosten TR, Rounsaville BJ, Babor TF, Spitzer RL, Williams JB. Substance-use disorders in DSM-III-R. Evidence for the dependence syndrome across different psychoactive substances. The British Journal of Psychiatry : the Journal of Mental Science. 151: 834-43. PMID 2901887 DOI: 10.1192/Bjp.151.6.834 |
0.39 |
|
| 1987 |
Kosten TR, Rounsaville BJ, Kleber HD. A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Archives of General Psychiatry. 44: 281-4. PMID 3827521 DOI: 10.1001/Archpsyc.1987.01800150101012 |
0.475 |
|
| 1987 |
Kosten TR, Rounsaville BJ, Kleber HD. Multidimensionality and prediction of treatment outcome in opioid addicts: 2.5-year follow-up. Comprehensive Psychiatry. 28: 3-13. PMID 3802797 DOI: 10.1016/0010-440X(87)90038-1 |
0.317 |
|
| 1987 |
Kosten TR, Jalali B, Steidl JH, Kleber HD. Relationship of marital structure and interactions to opiate abuse relapse. The American Journal of Drug and Alcohol Abuse. 13: 387-99. PMID 3687898 DOI: 10.3109/00952998709001523 |
0.312 |
|
| 1987 |
Rounsaville BJ, Kosten TR, Kleber HD. The antecedents and benefits of achieving abstinence in opioid addicts: a 2.5-year follow-up study. The American Journal of Drug and Alcohol Abuse. 13: 213-29. PMID 3687888 DOI: 10.3109/00952998709001511 |
0.347 |
|
| 1987 |
Kosten TR, Rounsaville BJ, Kleber HD. Predictors of 2.5-year outcome in opioid addicts: pretreatment source of income. The American Journal of Drug and Alcohol Abuse. 13: 19-32. PMID 3687883 DOI: 10.3109/00952998709001498 |
0.3 |
|
| 1987 |
Kleber HD, Topazian M, Gaspari J, Riordan CE, Kosten T. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. The American Journal of Drug and Alcohol Abuse. 13: 1-17. PMID 3687878 DOI: 10.3109/00952998709001497 |
0.321 |
|
| 1986 |
Kosten TR, Kreek MJ, Ragunath J, Kleber HD. Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts. Biological Psychiatry. 21: 217-20. PMID 3947698 DOI: 10.1016/0006-3223(86)90150-2 |
0.309 |
|
| 1986 |
Kosten TR, Rounsaville BJ, Kleber HD. A 2.5 year follow-up of treatment retention and reentry among opioid addicts Journal of Substance Abuse Treatment. 3: 181-189. PMID 3806731 DOI: 10.1016/0740-5472(86)90019-X |
0.375 |
|
| 1986 |
Kosten TR, Gawin FH, Rounsaville BJ, Kleber HD. Cocaine abuse among opioid addicts: Demographic and diagnostic factors in treatment American Journal of Drug and Alcohol Abuse. 12: 1-16. PMID 3788892 DOI: 10.3109/00952998609083739 |
0.469 |
|
| 1986 |
Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Archives of General Psychiatry. 43: 739-45. PMID 3729668 DOI: 10.1001/Archpsyc.1986.01800080025004 |
0.324 |
|
| 1986 |
Kosten TR, Rounsaville BJ, Kleber HD. A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Archives of General Psychiatry. 43: 733-8. PMID 3729667 DOI: 10.1001/Archpsyc.1986.01800080019003 |
0.329 |
|
| 1986 |
Rounsaville BJ, Kosten TR, Weissmann MM, Kleber HD. A 2.5-year follow-up of short-term interpersonal psychotherapy in methadone-maintained opiate addicts. Comprehensive Psychiatry. 27: 201-10. PMID 3709134 DOI: 10.1016/0010-440X(86)90041-6 |
0.322 |
|
| 1986 |
Kosten TR. Diagnosing depression with the DST and TRH in cocaine and opioid abusers. Journal of Substance Abuse Treatment. 3: 47-9. PMID 3090273 DOI: 10.1016/0740-5472(86)90008-5 |
0.412 |
|
| 1986 |
Kosten TR, Rounsaville BJ. Psychopathology in Opioid Addicts Psychiatric Clinics of North America. 9: 515-532. DOI: 10.1016/S0193-953X(18)30610-5 |
0.33 |
|
| 1985 |
Kosten TR, Rounsaville BJ, Kleber HD. Ethnic and gender differences among opiate addicts International Journal of the Addictions. 20: 1143-1162. PMID 4077316 DOI: 10.3109/10826088509056356 |
0.301 |
|
| 1985 |
Kleber HD, Riordan CE, Rounsaville B, Kosten T, Charney D, Gaspari J, Hogan I, O'Connor C. Clonidine in outpatient detoxification from methadone maintenance. Archives of General Psychiatry. 42: 391-4. PMID 3977557 DOI: 10.1001/Archpsyc.1985.01790270081009 |
0.334 |
|
| 1985 |
Rounsaville BJ, Kosten T, Kleber H. Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal. The Journal of Nervous and Mental Disease. 173: 103-10. PMID 3881558 DOI: 10.1097/00005053-198502000-00007 |
0.358 |
|
| 1985 |
Kleber HD, Kosten TR, Gaspari J, Topazian M. Nontolerance to the opioid antagonism of naltrexone Biological Psychiatry. 20: 66-72. PMID 2981129 DOI: 10.1016/0006-3223(85)90136-2 |
0.339 |
|
| 1983 |
Kosten TR, Jalali B, Hogan I, Kleber HD. Family denial as a prognostic factor in opiate addict treatment outcome Journal of Nervous and Mental Disease. 171: 611-616. PMID 6619824 DOI: 10.1097/00005053-198310000-00004 |
0.31 |
|
| 1983 |
Kosten TR, Rounsaville BJ, Kleber HD. Concurrent validity of the addiction severity index Journal of Nervous and Mental Disease. 171: 606-610. PMID 6619823 DOI: 10.1097/00005053-198310000-00003 |
0.334 |
|
| 1983 |
Kosten TR. Substance Abuse The Journal of Nervous and Mental Disease. 171: 754. DOI: 10.1097/00005053-198312000-00009 |
0.348 |
|
| Show low-probability matches. |
